BVF as of Sept. 30, 2022
Portfolio Holdings for BVF
BVF holds 80 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 7.2 | $173M | 22M | 7.96 | |
| Ionis Pharmaceuticals (IONS) | 5.2 | $127M | 2.9M | 44.23 | |
| Gh Research Ordinary Shares (GHRS) | 4.5 | $108M | 9.3M | 11.62 | |
| Kymera Therapeutics (KYMR) | 4.2 | $102M | 4.7M | 21.77 | |
| Repare Therapeutics Ord | 4.2 | $101M | 8.3M | 12.13 | |
| Relay Therapeutics (RLAY) | 4.0 | $97M | 4.3M | 22.37 | |
| Cullinan Oncology (CGEM) | 4.0 | $96M | 7.5M | 12.82 | |
| Relmada Therapeutics (RLMD) | 3.2 | $77M | 2.1M | 37.02 | |
| Crinetics Pharmaceuticals In (CRNX) | 3.0 | $72M | 3.7M | 19.64 | |
| Arcus Biosciences Incorporated (RCUS) | 2.9 | $71M | 2.7M | 26.16 | |
| Merus N V (MRUS) | 2.8 | $69M | 3.4M | 20.03 | |
| Third Harmonic Bio (THRD) | 2.7 | $66M | 3.5M | 18.97 | |
| Xoma Corp Del Com New (XOMA) | 2.7 | $65M | 3.6M | 17.91 | |
| Revolution Medicines (RVMD) | 2.7 | $64M | 3.3M | 19.72 | |
| Aclaris Therapeutics (ACRS) | 2.6 | $63M | 4.0M | 15.74 | |
| Cti Biopharma | 2.1 | $51M | 8.8M | 5.82 | |
| Ideaya Biosciences (IDYA) | 2.0 | $49M | 3.3M | 14.92 | |
| Kura Oncology (KURA) | 1.8 | $44M | 3.2M | 13.66 | |
| Point Biopharma Global | 1.8 | $43M | 5.6M | 7.73 | |
| Syndax Pharmaceuticals (SNDX) | 1.8 | $43M | 1.8M | 24.03 | |
| Cincor Pharma | 1.8 | $43M | 1.3M | 32.82 | |
| Lexicon Pharmaceuticals Com New (LXRX) | 1.6 | $39M | 16M | 2.40 | |
| Miragen Therapeutics (VRDN) | 1.5 | $36M | 1.7M | 20.51 | |
| Iteos Therapeutics | 1.4 | $35M | 1.8M | 19.05 | |
| Xenon Pharmaceuticals (XENE) | 1.3 | $33M | 901k | 36.10 | |
| Nuvalent Inc-a (NUVL) | 1.3 | $32M | 1.7M | 19.44 | |
| 4d Molecular Therapeutics In (FDMT) | 1.3 | $32M | 4.0M | 8.04 | |
| Cogent Biosciences (COGT) | 1.3 | $31M | 2.1M | 14.92 | |
| Allakos | 1.3 | $31M | 5.0M | 6.12 | |
| Eqrx | 1.2 | $30M | 6.0M | 4.95 | |
| An2 Therapeutics (ANTX) | 1.2 | $28M | 1.6M | 17.38 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.1 | $28M | 6.9M | 4.02 | |
| Concert Pharmaceuticals I equity | 1.0 | $24M | 3.6M | 6.70 | |
| Ac Immune Sa SHS (ACIU) | 1.0 | $24M | 7.4M | 3.16 | |
| Annexon (ANNX) | 1.0 | $23M | 3.8M | 6.18 | |
| Verve Therapeutics (VERV) | 0.9 | $22M | 650k | 34.35 | |
| Tyra Biosciences (TYRA) | 0.9 | $22M | 2.5M | 8.79 | |
| Olema Pharmaceuticals (OLMA) | 0.9 | $21M | 7.6M | 2.76 | |
| Janux Therapeutics (JANX) | 0.8 | $20M | 1.5M | 13.54 | |
| Sutro Biopharma | 0.8 | $19M | 3.4M | 5.55 | |
| 89bio (ETNB) | 0.8 | $18M | 3.1M | 5.79 | |
| Rain Therapeutics | 0.7 | $17M | 3.5M | 4.88 | |
| Verastem | 0.7 | $17M | 20M | 0.85 | |
| Vigil Neuroscience (VIGL) | 0.7 | $17M | 1.8M | 9.10 | |
| Replimune Group (REPL) | 0.7 | $16M | 927k | 17.27 | |
| Essa Pharma Com New (EPIX) | 0.7 | $16M | 8.7M | 1.82 | |
| Viracta Therapeutics (VIRX) | 0.6 | $15M | 3.6M | 4.27 | |
| Silence Therapeutics Ads (SLN) | 0.6 | $15M | 1.5M | 9.87 | |
| Ovid Therapeutics (OVID) | 0.5 | $13M | 6.9M | 1.84 | |
| Aadi Bioscience (WHWK) | 0.5 | $12M | 879k | 14.13 | |
| Calliditas Therapeutics Ab Sponsered Ads | 0.5 | $11M | 750k | 15.10 | |
| Cytomx Therapeutics (CTMX) | 0.4 | $9.6M | 6.6M | 1.45 | |
| Ikena Oncology (IKNA) | 0.4 | $8.9M | 2.5M | 3.55 | |
| Alpine Immune Sciences | 0.3 | $8.2M | 1.1M | 7.20 | |
| Infinity Pharmaceuticals (INFIQ) | 0.3 | $7.6M | 6.4M | 1.19 | |
| Hillevax | 0.3 | $6.5M | 383k | 17.09 | |
| Eledon Pharmaceuticals (ELDN) | 0.3 | $6.4M | 2.3M | 2.76 | |
| Pieris Pharmaceuticals | 0.2 | $5.8M | 5.1M | 1.15 | |
| Pyxis Oncology Common Stock (PYXS) | 0.2 | $5.8M | 2.9M | 1.97 | |
| Glycomimetics | 0.2 | $5.3M | 9.5M | 0.55 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.2 | $4.3M | 6.9M | 0.63 | |
| Spero Therapeutics (SPRO) | 0.2 | $3.9M | 1.9M | 2.00 | |
| Molecular Templates | 0.2 | $3.7M | 5.0M | 0.75 | |
| Molecular Partners Ads (MOLN) | 0.1 | $3.0M | 443k | 6.70 | |
| Inventiva Sa Ads (IVA) | 0.1 | $2.7M | 686k | 3.87 | |
| Elevation Oncology (ELEV) | 0.1 | $2.6M | 2.3M | 1.13 | |
| Selecta Biosciences | 0.1 | $2.3M | 1.4M | 1.64 | |
| Generation Bio | 0.1 | $1.9M | 362k | 5.31 | |
| Forward Pharma A/s Sponsord Ads New | 0.1 | $1.5M | 514k | 2.95 | |
| X4 Pharmaceuticals | 0.1 | $1.4M | 848k | 1.71 | |
| Calithera Biosciences Com New (CALA) | 0.1 | $1.4M | 465k | 2.94 | |
| Mei Pharma Com New | 0.1 | $1.4M | 3.5M | 0.39 | |
| Corvus Pharmaceuticals (CRVS) | 0.0 | $1.1M | 1.4M | 0.82 | |
| Aileron Therapeutics | 0.0 | $1.1M | 5.3M | 0.21 | |
| Angion Biomedica Corp | 0.0 | $986k | 1.1M | 0.92 | |
| Erytech Pharma Sponsored Adr | 0.0 | $690k | 1.3M | 0.52 | |
| Bionomics Ads | 0.0 | $578k | 81k | 7.14 | |
| Galmed Pharmaceuticals SHS | 0.0 | $558k | 1.8M | 0.31 | |
| Rezolute Com New (RZLT) | 0.0 | $523k | 191k | 2.74 | |
| Contrafect Corp Com New | 0.0 | $79k | 472k | 0.17 |
